이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Henry Schein 미래 성장

Future 기준 확인 3/6

Henry Schein (는) 각각 연간 24.7% 및 5.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 20.2% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 14.9% 로 예상됩니다.

주요 정보

24.2%

수익 성장률

19.2%

EPS 성장률

Healthcare 수익 성장	19.3%
매출 성장률	4.9%
향후 자기자본 수익률	14.7%
애널리스트 커버리지	Good
마지막 업데이트	20 Sep 2024

최근 미래 성장 업데이트

Recent updates

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Apr 14

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Feb 28

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Oct 11

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Sep 23

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Aug 21

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Aug 01

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jul 09

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Jun 09

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

May 21

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

May 01

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Apr 10

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Feb 15

Returns On Capital At Henry Schein (NASDAQ:HSIC) Have Stalled

Jan 28

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Jan 10

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Dec 11

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 43% Undervaluation?

Nov 04

Buy Henry Schein To Receive 'Resiliency Premium' In Equity Portfolios

Aug 25

Henry Schein announces $400M increase to stock buyback plan

Aug 18

If EPS Growth Is Important To You, Henry Schein (NASDAQ:HSIC) Presents An Opportunity

Aug 09

Henry Schein Q2 2022 Earnings Preview

Aug 01

Be Wary Of Henry Schein (NASDAQ:HSIC) And Its Returns On Capital

Jul 04

수익 및 매출 성장 예측

NasdaqGS:HSIC - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	14,103	658	800	1,062	10
12/31/2025	13,526	573	725	952	13
12/31/2024	12,939	447	667	859	13
6/29/2024	12,487	352	495	692	N/A
3/30/2024	12,451	388	473	670	N/A
12/30/2023	12,339	416	313	500	N/A
9/30/2023	12,693	445	597	786	N/A
7/1/2023	12,598	458	480	653	N/A
4/1/2023	12,528	478	387	536	N/A
12/31/2022	12,647	538	474	602	N/A
9/24/2022	12,607	638	528	625	N/A
6/25/2022	12,718	650	648	738	N/A
3/26/2022	12,655	646	656	740	N/A
12/25/2021	12,401	631	598	710	N/A
9/25/2021	12,236	626	723	783	N/A
6/26/2021	11,898	606	783	833	N/A
3/27/2021	10,615	438	544	583	N/A
12/26/2020	10,119	403	550	599	N/A
9/26/2020	9,622	591	477	542	N/A
6/27/2020	9,291	585	436	512	N/A
3/28/2020	10,054	713	683	766	N/A
12/28/2019	9,986	701	578	654	N/A
9/28/2019	9,789	488	585	655	N/A
6/29/2019	9,636	444	526	597	N/A
3/30/2019	9,504	438	648	722	N/A
12/29/2018	9,418	431	613	685	N/A
9/29/2018	10,263	304	553	629	N/A
6/30/2018	11,069	352	511	586	N/A
3/31/2018	11,812	377	N/A	527	N/A
12/30/2017	8,883	293	N/A	546	N/A
9/30/2017	12,264	554	N/A	572	N/A
7/1/2017	11,968	550	N/A	619	N/A
4/1/2017	11,782	534	N/A	668	N/A
12/31/2016	11,572	507	N/A	643	N/A
9/24/2016	11,302	498	N/A	676	N/A
6/25/2016	11,122	492	N/A	605	N/A
3/26/2016	10,879	489	N/A	536	N/A
12/26/2015	10,630	479	N/A	616	N/A
9/26/2015	10,481	482	N/A	563	N/A
6/27/2015	10,419	469	N/A	630	N/A
3/28/2015	10,405	467	N/A	621	N/A
12/27/2014	10,371	466	N/A	593	N/A
9/27/2014	10,196	457	N/A	593	N/A
6/28/2014	9,921	450	N/A	571	N/A
3/29/2014	9,697	442	N/A	647	N/A
12/28/2013	9,561	432	N/A	664	N/A

애널리스트 미래 성장 예측

수입 대 저축률: HSIC 의 연간 예상 수익 증가율( 24.7% )이 saving rate( 2.4% 보다 높습니다. ).

수익 vs 시장: HSIC 의 연간 수익( 24.7% ) US 시장( 14.9% 보다 빠르게 성장할 것으로 예상됩니다. 14.9% 연간).

고성장 수익: HSIC 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: HSIC 의 수익(연간 5.8% ) US 시장( 8.7% 보다 느리게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: HSIC 의 수익(연간 5.8% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: HSIC 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 14.9 %).

Henry Schein 미래 성장

Future 기준 확인 3/6

주요 정보

최근 미래 성장 업데이트

Price target decreased by 7.7% to US$73.27

Consensus EPS estimates fall by 12%

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

Recent updates

Henry Schein, Inc.'s (NASDAQ:HSIC) Popularity With Investors Is Clear

Henry Schein, Inc.(NasdaqGS:HSIC) dropped from FTSE All-World Index (USD)

Price target decreased by 7.7% to US$73.27

Insider recently sold US$1.5m worth of stock

Insider notifies of intention to sell stock

Henry Schein (NASDAQ:HSIC) Will Be Hoping To Turn Its Returns On Capital Around

Consensus EPS estimates fall by 12%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Time To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

Henry Schein, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Market Participants Recognise Henry Schein, Inc.'s (NASDAQ:HSIC) Earnings

Henry Schein: Acquisition Strategy Isn't Pulling Its Economic Weight

Here's Why Henry Schein (NASDAQ:HSIC) Has A Meaningful Debt Burden

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

Is It Too Late To Consider Buying Henry Schein, Inc. (NASDAQ:HSIC)?

There Are Reasons To Feel Uneasy About Henry Schein's (NASDAQ:HSIC) Returns On Capital

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Insider recently sold US$478k worth of stock

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Despite Disappointing Results, Henry Schein Looks Appealing Moving Forward

Full year 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Is Henry Schein (NASDAQ:HSIC) A Risky Investment?

Is There Now An Opportunity In Henry Schein, Inc. (NASDAQ:HSIC)?

Is There An Opportunity With Henry Schein, Inc.'s (NASDAQ:HSIC) 49% Undervaluation?

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS misses analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein (NASDAQ:HSIC) Might Be Having Difficulty Using Its Capital Effectively

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

These 4 Measures Indicate That Henry Schein (NASDAQ:HSIC) Is Using Debt Reasonably Well

Insider recently sold US$835k worth of stock

At US$74.94, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely?

Executive Vice Chairman & President notifies of intention to sell stock

Executive VP & COO notifies of intention to sell stock

Executive VP recently sold US$1.9m worth of stock

Executive VP notifies of intention to sell stock

Are Investors Undervaluing Henry Schein, Inc. (NASDAQ:HSIC) By 36%?

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Henry Schein (NASDAQ:HSIC) Hasn't Managed To Accelerate Its Returns

Here's Why Henry Schein (NASDAQ:HSIC) Can Manage Its Debt Responsibly

Independent Director recently sold US$148k worth of stock

Senior VP & Chief Legal Officer notifies of intention to sell stock

Independent Lead Director recently sold US$504k worth of stock

Independent Lead Director notifies of intention to sell stock

Independent Director recently sold US$923k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Henry Schein, Inc. Reports Impairment Charge on Intangible Assets for the Fourth Quarter Ended December 31, 2022

Now 25% undervalued

Estimating The Intrinsic Value Of Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein, Inc. (NasdaqGS:HSIC) announces an Equity Buyback for $400 million worth of its shares.